Suchergebnisse - "Guan, Xiuwen"

PubPharm (85)

51

Polymorphisms of MTHFR and TYMS predict capecitabine-induced hand-foot syndrome in patients with metastatic breast cancer

enthalten in: Chinese journal of cancer | 2019

von Lin, S. | Yue, J. | Guan, X. | +11

52

Safety, Efficacy, and Biomarker Analysis of Pyrotinib in Combination with Capecitabine in HER2-Positive Metastatic Breast Cancer Patients : A Phase I Clinical Trial

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2019

von Li, Q. | Guan, X. | Chen, S. | +16

53

Everolimus in hormone receptor-positive metastatic breast cancer : PIK3CA mutation H1047R was a potential efficacy biomarker in a retrospective study

enthalten in: BMC cancer | 2019

von Yi, Z. | Ma, F. | Liu, B. | +5

54

Everolimus in hormone receptor-positive metastatic breast cancer: PIK3CA mutation H1047R was a potential efficacy biomarker in a retrospective study

enthalten in: BMC cancer | 2019

von Yi, Z. | Ma, F. | Liu, B. | +5

55

Everolimus in hormone receptor-positive metastatic breast cancer: PIK3CA mutation H1047R was a potential efficacy biomarker in a retrospective study

enthalten in: BMC cancer | 2019

von Yi, Z. | Ma, F. | Liu, B. | +5

56

Efficient PD-L1 gene silence promoted by hyaluronidase for cancer immunotherapy

enthalten in: Journal of controlled release : official journal of the Controlled Release Society | 2019

von Guan, X. | Lin, L. | Chen, J. | +5

57

The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer

enthalten in: Cancer communications (London, England) | 2019

von Guan, X. | Ma, F. | Li, C. | +13

58

The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial–mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer

enthalten in: Cancer communications | 2019

von Guan, X. | Ma, F. | Li, C. | +13

59

The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial–mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer

enthalten in: Chinese journal of cancer | 2019

von Guan, X. | Ma, F. | Li, C. | +13

60

The association between early-onset cardiac events caused by neoadjuvant or adjuvant chemotherapy in triple-negative breast cancer patients and some novel autophagy-related polymorphisms in their genomic DNA : a real-world study

enthalten in: Cancer communications (London, England) | 2018

von Liu, B. | An, T. | Li, M. | +10